[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-EP2181990,2010,A1Locationinpatent:Page/Pagecolumn16
Title: Kikuchi A, et al. In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).Invest New Drugs. 2014 Oct;32(5):860-70.